Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 04 Dec 2025 08:00 CET |
THOR MEDICAL ASA | RadioMedix and Thor Medical enter supply agreement for thorium-228 | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Nov 2025 13:27 CET |
THOR MEDICAL ASA | Thor Medical ASA - New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Nov 2025 07:30 CET |
THOR MEDICAL ASA | Thor Medical enters supply agreement with NucliThera for thorium-228 | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Nov 2025 07:30 CET |
THOR MEDICAL ASA | Thor Medical strengthens executive team to realise leadership ambitions in targeted alpha therapies | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Nov 2025 23:15 CET |
THOR MEDICAL ASA | Thor Medical - Issuance of RSU shares to members of the board | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 06 Nov 2025 07:30 CET |
THOR MEDICAL ASA | Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thorium-228 | 20103010 Biotechnology | Inside information |
| 29 Aug 2025 07:15 CEST |
THOR MEDICAL ASA | Thor Medical ASA interim results for 1H 2025 - strong operational and commercial progress | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 29 Aug 2025 07:00 CEST |
THOR MEDICAL ASA | Thor Medical and Oncoinvent Enter Strategic Thorium-228 Supply Agreement | 20103010 Biotechnology | Inside information |
| 22 Aug 2025 08:00 CEST |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00 | 20103010 Biotechnology | Non-regulatory press releases |
| 04 Aug 2025 07:30 CEST |
THOR MEDICAL ASA | Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228 | 20103010 Biotechnology | Inside information |
| 01 Aug 2025 08:58 CEST |
THOR MEDICAL ASA | Thor Medical ASA - Share capital increase in relation to Subsequent Offering is registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 04 Jul 2025 10:41 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Final results of the Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jul 2025 07:00 CEST |
THOR MEDICAL ASA | Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16:30 CEST today | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Jun 2025 14:33 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Primary insider notification and disclosure of large shareholdings | 20103010 Biotechnology | Major shareholding notifications |
| 26 Jun 2025 14:24 CEST |
THOR MEDICAL ASA | Thor Medical ASA - Share capital increase in relation to the Private Placement and the PrimaryBid Offering is registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 26 Jun 2025 07:00 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Commencement of the subscription period for the subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Jun 2025 18:58 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Registration of national prospectus and launch of subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Jun 2025 07:30 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Ex. right to participate in subsequent offering today | 20103010 Biotechnology | Ex Date |
| 18 Jun 2025 23:46 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Key information relating to potential subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Jun 2025 23:41 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Primary insider transaction and disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 18 Jun 2025 23:32 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Private placement and retail offering through PrimaryBid successfully completed | 20103010 Biotechnology | Inside information |
| 18 Jun 2025 16:30 CEST |
THOR MEDICAL ASA | Thor Medical ASA - Contemplated private placement and retail offering through PrimaryBid | 20103010 Biotechnology | Inside information |
| 16 Jun 2025 07:30 CEST |
THOR MEDICAL ASA | Thor Medical signs strategic sales agreement for Thorium-228 with global leader in targeted alpha therapy | 20103010 Biotechnology | Inside information |
| 05 Jun 2025 16:32 CEST |
THOR MEDICAL ASA | Flagging – Thor Medical ASA – passerer 5?% | 20103010 Biotechnology | Flagging |
| 13 May 2025 16:45 CEST |
THOR MEDICAL ASA | Thor Medical sign strategic supply agreement for feedstock of thorium | 20103010 Biotechnology | Inside information |
| 02 May 2025 23:06 CEST |
THOR MEDICAL ASA | Thor Medical - Primary insider notifications - Grant of restricted stock units (RSU) to the members of the board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 May 2025 19:55 CEST |
THOR MEDICAL ASA | Thor Medical - Grant of restricted stock units (RSU) to the members of the board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Apr 2025 15:03 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Completion of annual general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Apr 2025 18:27 CEST |
THOR MEDICAL ASA | Flagging Thor Medical ASA 11 April 2025 | 20103010 Biotechnology | Major shareholding notifications |
| 11 Apr 2025 08:50 CEST |
THOR MEDICAL ASA | Flagging Thor Medical ASA 11.04.2025 | 20103010 Biotechnology | Flagging |
| 09 Apr 2025 15:19 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associates of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 09 Apr 2025 08:13 CEST |
THOR MEDICAL ASA | Flagging Thor Medical ASA | 20103010 Biotechnology | Flagging |
| 04 Apr 2025 10:52 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associates of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 03 Apr 2025 08:38 CEST |
THOR MEDICAL ASA | Thor Medical ASA - Notice of Annual General Meeting on 24 April 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Mar 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA publishes Annual report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 25 Mar 2025 16:46 CET |
THOR MEDICAL ASA | Thor Medical makes final investment decision for AlphaOne - ready for commercial production in 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Feb 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA interim and full-year 2024 results - closing in on commercial launch | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 20 Feb 2025 08:00 CET |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's second half and full year results 2024 | 20103010 Biotechnology | Non-regulatory press releases |
| 10 Feb 2025 09:25 CET |
THOR MEDICAL ASA | Thor Medical ASA: Share capital increase in relation to Subsequent Offering registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 24 Jan 2025 20:17 CET |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 24 Jan 2025 20:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Final results of the Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Jan 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: The Subscription Period in the Subsequent Offering ends today at 12:30 CET | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Jan 2025 16:27 CET |
THOR MEDICAL ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Jan 2025 14:01 CET |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associate of primary insider | 20103010 Biotechnology | Meldepliktig handel for primærinnsidere |
| 15 Jan 2025 11:01 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholdings | 20103010 Biotechnology | Flagging |
| 15 Jan 2025 10:31 CET |
THOR MEDICAL ASA | Thor Medical ASA: Share capital increase in relation to Tranche 2 of the Private Placement is registered | 20103010 Biotechnology | Changes in the rights attaching to the classes of shares or securities |
| 13 Jan 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Commencement of the subscription period for the subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Jan 2025 13:30 CET |
THOR MEDICAL ASA | Thor Medical ASA: Approval of prospectus and launch of subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Jan 2025 07:45 CET |
THOR MEDICAL ASA | Thor Medical secures NOK 90 million loan from Innovation Norway, ensuring full financing of AlphaOne | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Jan 2025 15:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholding - share lending | 20103010 Biotechnology | Flagging |